ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 903,29
0,23%
DAX
17 932,17
-1,10%
Brent Oil
83,765
0,27%
Bitcoin
57 367,57
-1,49%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. PTC Therapeutics Inc (PTCT)

  7. PTC Therapeutics Inc (PTCT) Actualités

PTCT PTC Therapeutics Inc

34,16
2,01 (6,25%)
01 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
PTC Therapeutics Inc PTCT NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
2,01 6,25% 34,16 23:30:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
32,31 31,70 35,47 34,16 32,15
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
25/4/202422:05PRNUSPTC Therapeutics Provides Corporate Update and Reports First..
23/4/202422:30PRNUSPTC Therapeutics Reports Inducement Grants Under Nasdaq..
11/4/202414:00PRNUSPTC Therapeutics to Host Conference Call to Discuss First..
28/3/202413:30PRNUSPTC Announces Submission of Sepiapterin MAA for Treatment of..
19/3/202412:30PRNUSPTC Therapeutics Provides Key Regulatory Updates
29/2/202422:05PRNUSPTC Therapeutics Provides Corporate Update and Reports..
27/2/202423:20PRNUSPTC Therapeutics to Participate at Upcoming Investor..
22/2/202422:30PRNUSPTC Therapeutics Reports Inducement Grants Under Nasdaq..
16/2/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202414:00PRNUSPTC Therapeutics to Host Conference Call to Discuss Fourth..
14/2/202421:50EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202413:13EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202421:30EDGAR2Form 144 - Report of proposed sale of securities
30/1/202421:25EDGAR2Form 144 - Report of proposed sale of securities
30/1/202421:18EDGAR2Form 144 - Report of proposed sale of securities
30/1/202421:18EDGAR2Form 144 - Report of proposed sale of securities
30/1/202421:17EDGAR2Form 144 - Report of proposed sale of securities
25/1/202422:06EDGAR2Form 8-K - Current report
25/1/202422:05PRNUSCHMP Issues Negative Opinion for Renewal of Conditional..
24/1/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202422:11EDGAR2Form 144 - Report of proposed sale of securities
10/1/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202423:46EDGAR2Form 144 - Report of proposed sale of securities
09/1/202422:35EDGAR2Form 144 - Report of proposed sale of securities

Dernières Valeurs Consultées

NASDAQ
PTCT
PTC Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés